Internal Medicine, Rheumatology · New York, NY
NPI
1134193451
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
333 E 38th St, NYU Center for Musculoskeletal Care
New York, NY, 10016
Phone (646) 501-7400
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$4.8M
2,387 prescriptions
Company payments, 2025
$7,187
From 4 companies
Medicare prescription drug claims, 2024
In 2024, the drug Gary E Solomon prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 307 prescriptions and refills. In total Gary E Solomon wrote 2,387 Medicare prescriptions that cost $4.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-10-04.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Methotrexate Methotrexate Sodium | 307 | 755 | 105 | $9,426 |
| Prednisone Generic | 275 | 403 | 90 | $3,012 |
| Xeljanz Xr Tofacitinib Citrate | 149 | 153 | 16 | $929K |
| Hydroxychloroquine Sulfate Generic | 96 | 210 | 27 | $4,966 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 80 | 89 | Under 11 | $782K |
| Rinvoq Upadacitinib | 79 | 99 | Under 11 | $622K |
| Enbrel Sureclick Etanercept | 78 | 90 | 11 | $702K |
| Levothyroxine Sodium Generic | 74 | 180 | 21 | $1,092 |
| Meloxicam Generic | 73 | 131 | 19 | $501 |
| Folic Acid Generic | 66 | 192 | 24 | $867 |
| Gabapentin Generic | 58 | 95 | 17 | $1,086 |
| Rosuvastatin Calcium Generic | 53 | 159 | 16 | $591 |
| Methotrexate Sodium Methotrexate Sodium/Pf | 47 | 58 | 14 | $543 |
| Metformin Hcl Er Metformin Hcl | 46 | 114 | 11 | $341 |
| Celecoxib Generic | 40 | 86 | 12 | $1,148 |
Brand drugs: 669 claims; generic drugs: 1,691 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gary E Solomon $7,187 ($7,187 in general payments such as food, travel and fees) from 4 companies. The largest payer was Abbvie Inc. with $6,887.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.